Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir

Sophie José(NHS England), Frank A. Post(King's College Hospital NHS Foundation Trust), Lisa Hamzah, Rachael Jones(Chelsea and Westminster Hospital NHS Foundation Trust), Roy Trevelion, Caroline Sabin(Primary Health Care), Mark Nelson(University of Tasmania), Andrew Phillips(Wake Forest University), David Chadwick(Lancaster University), Deborah I. Williams

AIDS

December 6, 2016

10.1097/qad.0000000000001353

Cited by 33

Related Papers

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

|Hepatology|2006|4.8k

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

|JAMA|2016|1.4k

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

|The Lancet|2019|1k

Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study

|AIDS|2003|987

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

|The Lancet|2014|930